Finally, Syk inhibition significantly prolonged survival of NSG mice transplanted with patient-derived AML cells overexpressing HOXA9 and MEIS1, with no significant difference for HOXA9 alone (Figure 7K). This evidence concerns the gene HOXA9 and acute myeloid leukemia.